Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN)
$296.85 USD
Updated Aug 16 12:00am
Add REGN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all “A” rated Strong Buy stocks
REGN Stock Chart More Charts
REGN Price/Volume Stats
| Current price | $296.85 |
| Prev. close | $293.11 |
| Day low | $290.72 |
| Day high | $297.35 |
| 50-day MA | $305.62 |
| 200-day MA | $357.39 |
| 52-week high | $442.00 |
| 52-week low | $287.66 |
| Volume | 742,500 |
| Avg. volume | 792,554 |
| Dividend yield | N/A |
| Market Cap | 32.60B |
Regeneron Pharmaceuticals, Inc. (REGN) Company Bio
Regeneron Pharmaceuticals is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for eye diseases, high LDL-cholesterol and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, and atopic dermatitis. The company was founded in 1988 and is based in Tarrytown, New York.
Top Stories View All
Sweet 16 Safe Stocks for this Volatile Market
Does 1 Equation Hold the Key for Stock Prices?
Best & Worst Performing Stock Industries for August 16, 2019
Best & Worst Performing Small Cap Stocks for August 16, 2019
Best & Worst Performing Mid Cap Stocks for August 16, 2019
View All Top Stories
Loading social stream, please wait...